MIRM Mirum Pharmaceuticals Inc

USD 40.45 +0.05 ( +0.12)%
Icon

Mirum Pharmaceuticals Inc (MIRM) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 40.45

+0.05 (+0.12)%

N/A

0.36M

USD 55.97(+38.38%)

USD 22.00 (-45.61%)

Icon

MIRM

Mirum Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 40.45
+0.05 ( +0.12)%
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

N/A

USD 22.00 (-45.61%)

USD 40.45

Mirum Pharmaceuticals Inc (MIRM) Stock Forecast

Show ratings and price targets of :
USD 55.97
(+38.38%)

Based on the Mirum Pharmaceuticals Inc stock forecast from 10 analysts, the average analyst target price for Mirum Pharmaceuticals Inc is USD 55.97 over the next 12 months. Mirum Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Mirum Pharmaceuticals Inc is Neutral, which is based on 1 positive signals and 1 negative signals. At the last closing, Mirum Pharmaceuticals Inc’s stock price was USD 40.45. Mirum Pharmaceuticals Inc’s stock price has changed by +2.30% over the past week, +3.03% over the past month and +34.83% over the last year.

No recent analyst target price found for Mirum Pharmaceuticals Inc
No recent average analyst rating found for Mirum Pharmaceuticals Inc

Company Overview Mirum Pharmaceuticals Inc

N/A

N/A

N/A

N/A

USD

USA

Adjusted Closing Price for Mirum Pharmaceuticals Inc (MIRM)

Loading...

Unadjusted Closing Price for Mirum Pharmaceuticals Inc (MIRM)

Loading...

Share Trading Volume for Mirum Pharmaceuticals Inc Shares

Loading...

Compare Performance of Mirum Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for MIRM

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Mirum Pharmaceuticals Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc +1.68 (+0.36%) USD121.60B 32.57 250.99

Frequently Asked Questions About Mirum Pharmaceuticals Inc (MIRM) Stock

Based on ratings from 10 analysts Mirum Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 19 buy, sell and hold ratings.

Unfortunately we do not have enough data on MIRM's stock to indicate if its a good dividend stock.

Based on targets from 10 analysts, the average taret price for MIRM is USD 55.97 over the next 12 months. The maximum analyst target price is USD 69 while the minimum anlayst target price is USD 38.

Unfortunately we do not have enough data on MIRM's stock to indicate if its overvalued.

The last closing price of MIRM's stock was USD 40.45.

Unfortunately we do not currently have any market capitalization data for MIRM's stock.

Based on targets from 10 analysts, the average taret price for MIRM is projected at USD 55.97 over the next 12 months. This means that MIRM's stock price may go up by +38.38% over the next 12 months.

We can't find any ETFs which contains Mirum Pharmaceuticals Inc's stock.

Sorry, we do not have any data on the number of employees for Mirum Pharmaceuticals Inc.

Sorry we do not have any infomation available on Mirum Pharmaceuticals Inc's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Mirum Pharmaceuticals Inc (MIRM) Stock

Based on ratings from 10 analysts Mirum Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 19 buy, sell and hold ratings.

Unfortunately we do not have enough data on MIRM's stock to indicate if its a good dividend stock.

Based on targets from 10 analysts, the average taret price for MIRM is USD 55.97 over the next 12 months. The maximum analyst target price is USD 69 while the minimum anlayst target price is USD 38.

Unfortunately we do not have enough data on MIRM's stock to indicate if its overvalued.

The last closing price of MIRM's stock was USD 40.45.

Unfortunately we do not currently have any market capitalization data for MIRM's stock.

Based on targets from 10 analysts, the average taret price for MIRM is projected at USD 55.97 over the next 12 months. This means that MIRM's stock price may go up by +38.38% over the next 12 months.

We can't find any ETFs which contains Mirum Pharmaceuticals Inc's stock.

Sorry, we do not have any data on the number of employees for Mirum Pharmaceuticals Inc.

Sorry we do not have any infomation available on Mirum Pharmaceuticals Inc's address.
Loading...